Product Images Lonsurf

Lonsurf is a medication available in tablet form with a National Drug Code (NDC) of 64842-1020-1. It contains trifluridine and tipiracil hydrochloride and is manufactured by Taiho Pharmaceutical Co., Ltd. The tablets are made to be prescribed only and the usual dose can be found in the prescribing information. Proper storage should be at temperatures ranging from 20°C to 25°C.*

Lonsurf is a tablet for oral administration with each tablet containing Trifluidine and Tipiracil. The tablet is produced by Taino Pharmaceutical Co., Ltd, Japan, and comes in different dosages as indicated by the NDC number. The tablet should be stored at a temperature of 20° to 25°C, and any unused tablet disposed of in line with local requirements. It is important to wash hands after handling the tablets.*

Lonsurf is a medication in tablet form containing 20mg trifluridine and 8.19mg of tipiracil, manufactured by Taiho Pharmaceutical Co., Ltd in Japan and manufactured for Taiho Oncology, Inc. in the USA. The tablets come in a bottle of 40 and should be stored at a temperature of 20°C to 25°C. Detailed information on the appropriate dose is available in the prescribing information. Lot and expiration dates are also provided.*

Lonsurf (trifluridine and tipiracil) tablets are available in two dosages, 20mg/8.19mg and 15mg/6.14mg. It is indicated for metastatic colorectal cancer which is not responding to chemotherapy. Usual dosage and product information is available. Tablets should be stored at 20°C to 25°C and washed hands after handling them. Tipiracil hydrochloride is one of the key ingredients of the tablet, with each tablet containing 20mg of Trifluidine and 819mg of Tipiracil. Tablets must be disposed of as per local requirements.*

Lonsurf is a prescription medication available in the form of tablets. Each tablet contains 20mg trifluridine and 8.19 mg of tipiracil hydrochloride. It is used as per the prescribing information provided. The medication is manufactured by Taiho Pharmaceutical Co., Ltd., Japan and is distributed by Taiho Oncology, Inc. The tablets should be stored at a temperature of 20° to 25°C (68° to 77°F) with permissible excursions from 15° to 30°C (59° to 86°F) as per USP Controlled Room Temperature. The NDC number for this medication is 64842-1020-3.*

Lonsurf is a medication that contains both Trifluridine and Tipiracil. The medication is manufactured in Japan and distributed by Taiho Oncology Inc. Each tablet contains 20mg of Trifluridine and 8.19mg of Tipiracil hydrochloride. The normal dosage should be seen in the prescribing information. It is advised to wash hands after the handling of tablets. Any unused tablets should be disposed of according to the instructions of local requirements. The storage temperature of the medication should be between 20°C and 25°C.*

The text seems to be a graph representing data over time in months for a given study. The y-axis seems to be the number of risks, while the x-axis is time (in months). There are two lines plotted in the graph, one representing "Tirignetpraci" and the other "Placebo". However, there is not enough information to infer what the study is about or the context of the graph.*

This appears to be a chart or a graph that depicts the survival probability for two groups over a period of 20 months from randomization. The two groups are labeled "NatRisk" and "Placcho." The percentage of survival probability is shown on the Y-axis against the months from randomization depicted on the X-axis. However, without additional context, it is not possible to determine the nature of the study, the groups being compared, and what the numbers represent.*

Lonsurf is a prescription drug available in the form of tablets. Each tablet contains 15mg of trifluridine and 6.14mg of tipiracil, manufactured by Taiho Pharmaceutical Co., Ltd., Japan, and distributed by Taiho Oncology, Inc. The tablets come in a pack of 20 and the usual dose is mentioned in the prescribing information. The drug should be stored at a temperature of 20° to 25°C (68° to 77°F) with excursions permitted from 15° to 30°C (59° to 86°F). The packaging includes the NDC code of 64842-1025-1 and a LOT and EXP number.*

Lonsurf is an oral medication indicated for treating metastatic colorectal cancer. It contains a combination of Trifluridine (15mg) and Tipiracil (6.14mg) and comes in a package of 20 tablets. It is manufactured by Taino Pharmaceutical Co., Japan, and distributed by Taiho Oncology, Inc., Princeton, NJ, USA. The tablets should be disposed of according to local requirements, and unused tablets must be kept at 20° to 25°C. The recommended dosage should be determined by a physician based upon the patient's medical history.*

NDC 64842-1025-2 is a prescription drug with 40 tablets in a pack, named Lonsurf. It comprises 15mg Trifluridine and 6.14mg of tipiracil( equivalent to 7.065mg of tipiracil hydrochloride) and manufactured by Taiho Pharmaceutical C0., Ltd., Japan for Taiho Oncology, Inc. This medicine is intended to store at 20° to 25°C (68° to 77°F); excursions and direction are given in the text. The typical dosage of the medicine and a lot of the drug is not available.*

This is a description of a drug called Lonsurf, manufactured by Taino Pharmaceutical Co. Ltd. Each tablet contains Trifluidine 15mg and Tipiracil 614mg (equivalent to 7,065mg tipiracil hydrochloride). Lonsurf is used for oral administration, and 40 tablets are included. Usual dose and storage guidelines are included. Dispose of unused tablets according to local requirements. The National Drug Code for this drug is 64842-1025-2.*

Lonsurf is a prescription medication containing 15mg of trifluridine and 6.14mg of tipiracil. The tablets are packaged with 60 tablets per container and are manufactured by Taiho Pharmaceutical Co., Ltd. It is meant for oral consumption and should be stored at a temperature of 20° to 25°C (68° to 77°F) with excursions permitted from 15° to 30°C (59° to 86°F). The American USP Controlled Room Temperature guidelines should be followed. Further instructions on dosage can be found in the prescribing information. The NDC code is 64842-1025-3.*

This is a description of a medication called Lonsurf. It contains two active ingredients, Trifluidine 15mg and Tipiracil 61mg, which is equivalent to 7065mg of tipiracil hydrochloride. The medication is intended for oral administration and is sold in a bottle consisting of 60 tablets. The usual dosage is to be determined by the prescribing physician. It is recommended to wash your hands after handling the medication. The unused tablets should be disposed of as per local regulations. The manufacturing of this medicine is done by Taino Pharmaceutical Co. Ltd., and it is manufactured for Taiho Oncology Inc. The storage of Lonsurf should be done at a temperature between 20 to 25°C with excursions allowed from 15° to 30°C.*